Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AMAG Pharmaceuticals Inc (NASDAQ:AMAG)

19.05
Delayed Data
As of 4:00pm ET
 -0.20 / -1.04%
Today’s Change
16.00
Today|||52-Week Range
36.83
-45.26%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues80.9M124.4M418.3M532.1M
 
 
 
 
 
Cost of Goods Sold10.8M13.3M20.5M29.5M
 
 
 
 
 
Depreciation And Amortization1.2M7.0M69.1M99.9M
 
 
 
 
 
 
Operating ExpensesGross Income68.9M104.1M328.7M402.7M
 
 
 
 
 
General Expenses76.0M97.1M197.9M277.7M
 
 
 
 
 
Research And Development20.6M24.2M42.9M66.1M
 
 
 
 
 
Total Operating Expenses88.0M117.4M287.4M407.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-7.1M7.0M130.9M124.9M
 
 
 
 
 
Extraordinary Credit--681.0K0.000.00
 
 
Extraordinary Charge-4.5M-11.5M-32.5M-46.1M
 
 
 
 
 
Interest Expense On Debt--14.7M60.0M73.2M
 
 
 
 
Other Expenses964.0K217.0K1.5M189.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-9.6M-17.3M39.8M9.1M
 
 
 
 
 
Income Taxes0.00-153.2M-7.1M-11.5M
 
 
 
 
Net Income-9.6M135.8M32.8M-2.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS21.7M22.4M31.5M34.3M
 
 
 
 
 
Shares To Calculate EPS Diluted21.7M25.2M35.3M34.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.44$5.45$0.93-$0.07
 
 
 
 
 
EPS Diluted-$0.44$5.38$0.93-$0.07